Viridian Therapeutics Inc (VRDN)

NASDAQ · Biotechnology

23.03
-0.13 (-0.56%)
Updated Sep 1, 8:27 PM ET
AI Rating
Hold
Overall Score
57
Trend
50
Momentum
64
Risk
58

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 18, 2025 260 sessions Aug 28, 2026

AI Analysis

Viridian Therapeutics Inc is trading at $23.03, down 0.56% on the session. The 50 day average sits at $20.51 and the 200 day at $23.93, which puts the stock in a downtrend. RSI is at 55.7, which reads as strong, and MACD is bearish crossover. Volume is below average.

The nearest support is around $21.62 with resistance near $23.83, so that band frames the current range. Average daily movement is roughly $0.87, or about 3.8% of the share price, which is what any stop placement has to allow for. The overall health score of 57 out of 100 combines a trend score of 50, momentum of 64 and a risk score of 58.

Technical indicators

RSI (14)
55.7
strong
MACD
1.079
bearish crossover
SMA 20
23.02
SMA 50
20.51
SMA 200
23.93
downtrend
ATR (14)
0.87
avg daily range
Support
21.62
Resistance
23.83
Volume vs 20d
0.46x
below average
Volatility
50.8%
annualised
1 month
+15.98%
3 months
+30.99%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.